Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

2,661 questions · 2,751 findings · 453 reviews

No studies found 593 · 21.6%GRADE not reported 277 · 10.1%Very low 538 · 19.6%Low 712 · 25.9%Moderate 516 · 18.8%High 115 · 4.2%

Summary of findings: feedback on medication adherence to physicians vs usual care

Patient outcomes Lipid levels, HbA1C level, HIV viral load, number of major atherosclerosis disease events · any physician, and any patient treated for chronic diseases with long‐term medication use
1 finding from 1 review

Summary of findings: feedback on medication adherence to physicians vs usual care

Health resource use Rate of hospitalisations, rate of emergency department encounters, rate of outpatient encounters, rate of oral steroid use · any physician, and any patient treated for chronic diseases with long‐term medication use
1 finding from 1 review

Summary of findings: feedback on medication adherence to physicians vs usual care

Processes of care Rate of medication change (medication discontinued, added, replaced), proportion of visits with appropriate management of uncontrolled hypertension, patient rating (quality of care, duration of the visit, communication with physi... · any physician, and any patient treated for chronic diseases with long‐term medication use
1 finding from 1 review

Low molecular weight heparin vs vitamin K antagonist (VKA)

Recurrent VTE · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE

LMWH showed no clear difference in incidence of recurrent VTE (treatment duration 3 months) compared with VKA (moderate certainty).

1 finding from 1 review

Low molecular weight heparin vs vitamin K antagonist (VKA)

Major bleeding · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE

LMWH may leads to lower incidence of major bleeding (treatment duration 3 months) compared with VKA (low certainty).

1 finding from 1 review

Low molecular weight heparin vs vitamin K antagonist (VKA)

Mortality (treatment duration 3 months) · patients with symptomatic VTE requiring long term treatment (3 months) for symptomatic VTE

LMWH showed no clear difference in mortality (treatment duration 3 months) compared with VKA (moderate certainty).

1 finding from 1 review